We are live on ! Find out more
BFM

Boston Financial Management Portfolio holdings

AUM $3.31B
1-Year Est. Return 19.4%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
+19.4%
3 Year Est. Return
+30.07%
5 Year Est. Return
+107.8%
10 Year Est. Return
+274.5%
AUM
$758M
AUM Growth
+$10.8M
Cap. Flow
-$14.1M
Cap. Flow %
-1.86%
Top 10 Hldgs %
25.76%
Holding
210
New
11
Increased
76
Reduced
102
Closed
7

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$5.96M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$2.44M
3
XOM icon
ExxonMobil
XOM
+$2.29M
4
ABBV icon
AbbVie
ABBV
+$2.07M
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$1.88M

Sector Composition

Rank Sector Weight
1 Healthcare 22.8%
2 Energy 11.9%
3 Industrials 11.23%
4 Consumer Staples 10.78%
5 Technology 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMS icon
126
Fresenius Medical Care
FMS
$13.8B
$1.46M 0.19%
43,593
-1,869
-4% -$62.3K
VWO icon
127
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$1.45M 0.19%
33,693
+3,343
+11% +$141K
DD
128
DELISTED
Du Pont De Nemours E I
DD
$1.43M 0.19%
23,013
-1,211
-5% -$77.8K
ETP
129
DELISTED
Energy Transfer Partners L.p.
ETP
$1.39M 0.18%
24,033
+325
+1% +$18.2K
FLR icon
130
Fluor
FLR
$7.01B
$1.38M 0.18%
17,999
+55
+0.3% +$4.19K
TEVA icon
131
Teva Pharmaceuticals
TEVA
$40.8B
$1.38M 0.18%
26,306
+7,375
+39% +$377K
EEP
132
DELISTED
Enbridge Energy Partners
EEP
$1.37M 0.18%
37,100
-390
-1% -$12K
NVS icon
133
Novartis
NVS
$297B
$1.36M 0.18%
16,829
+307
+2% +$24.1K
BA icon
134
Boeing
BA
$171B
$1.35M 0.18%
10,625
+55
+0.5% +$7.18K
STT icon
135
State Street
STT
$50.6B
$1.34M 0.18%
19,917
-13,680
-41% -$900K
HSBC icon
136
HSBC
HSBC
$365B
$1.31M 0.17%
29,909
-1,700
-5% -$75.8K
FNSR
137
DELISTED
Finisar Corp
FNSR
$1.23M 0.16%
62,430
-400
-0.6% -$9.62K
RDS.A
138
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.23M 0.16%
14,924
+186
+1% +$14.5K
RAX
139
DELISTED
Rackspace Hosting Inc
RAX
$1.22M 0.16%
36,330
+10,035
+38% +$333K
ROP icon
140
Roper Technologies
ROP
$38.8B
$1.22M 0.16%
8,330
-25
-0.3% -$3.49K
EFA icon
141
iShares MSCI EAFE ETF
EFA
$78B
$1.21M 0.16%
17,757
+2,874
+19% +$197K
GL icon
142
Globe Life
GL
$14.2B
$1.16M 0.15%
21,285
+319
+2% +$17.1K
IWM icon
143
iShares Russell 2000 ETF
IWM
$79.8B
$1.08M 0.14%
9,123
-2,597
-22% -$295K
RTN
144
DELISTED
Raytheon Company
RTN
$1.08M 0.14%
11,697
-10,592
-48% -$1.03M
BRCM
145
DELISTED
BROADCOM CORP CL-A
BRCM
$1.05M 0.14%
28,332
-5,375
-16% -$176K
SEP
146
DELISTED
Spectra Engy Parters Lp
SEP
$1.05M 0.14%
19,665
+1,125
+6% +$58.9K
ADT
147
DELISTED
ADT Corp
ADT
$939K 0.12%
26,884
-3,365
-11% -$108K
IAU icon
148
iShares Gold Trust
IAU
$62.9B
$830K 0.11%
32,239
-812
-2% -$20.3K
OXY icon
149
Occidental Petroleum
OXY
$56.8B
$807K 0.11%
8,209
+1,096
+15% +$103K
SPY icon
150
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$782K 0.1%
3,998
+10
+0.3% +$1.9K

Similar funds

Boston Financial Management's Q2 2014 Portfolio in Review

As of Q2 2014, Boston Financial Management held 210 positions worth $758M, up 1.5% from $747M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Boston Financial Management's Q2 2014 filing shows 11 new, 76 increased, 102 reduced and 7 closed positions. Its largest new stake was Theravance Biopharma: 16,982 shares worth $541K. The largest sale was IBM, an estimated $5.96M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Energy and Industrials.

  • Boston Financial Management's largest Q2 2014 buy was Theravance Biopharma: 16,982 shares worth $541K.
  • Boston Financial Management added most to Berkshire Hathaway Class B in Q2 2014, an estimated $1.43M increase.
  • Boston Financial Management's biggest Q2 2014 reduction was IBM, cutting an estimated $5.96M.
  • Boston Financial Management fully exited Vanguard Morningstar Total Stock Market ETF in Q2 2014, selling an estimated $1.38M.
  • Boston Financial Management's ten largest holdings make up 26% of its $758M portfolio in Q2 2014.
  • Boston Financial Management opened 11 new positions and closed 7 in Q2 2014.
  • Boston Financial Management's portfolio value rose 1.5% quarter-over-quarter to $758M.

Based on Boston Financial Management's 13F filing for Q2 2014, filed 20 Aug 2014.